- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 69
Daily Deal Round Up: June 18, 2021
Behavioural health platform developer Brightline captured $72m in a round led by GV, while Gopuff is set to buy Siemens and ST-backed mobility software producer RideOS.
Jun 18, 2021Circle Pharma draws $66m series C
The oncology therapeutics developer has added $66m to its coffers thanks to investors including Berkeley Catalyst Fund.
Jun 18, 2021Mnemo Therapeutics redeems $91m
Alexandria Venture Investments was among the participants in a series A for the cellular cancer therapeutics developer based on work at Institut Curie and Memorial Sloan Kettering.
Jun 18, 2021Mnemo Therapeutics redeems $91m
Alexandria Venture Investments was among the participants in a series A round for the cellular cancer therapeutics developer.
Jun 18, 2021Daily Deal Round Up: June 17, 2021
11Street and CJ Group contributed to a $71.8m round for on-demand logistics provider Barogo while Eli Lilly helped provide $66m for macrocycle drug developer Circle Pharma.
Jun 17, 2021The Pill Club swallows more series B funds
GV has participated in a $41.9m series B extension for the birth control delivery service, which increased the round's size to $92.9m.
Jun 17, 2021Daily Deal Round Up: June 16, 2021
Bitwise Asset Management completed a $70m round backed by Coinbase at a $500m-plus valuation, while luxury goods wholesaler Joor raised $46m to take its overall funding to $81m.
Jun 16, 2021Duda develops with $50m series D
Susquehanna Growth Equity has returned to reinvest in the web design platform operator, which has amassed $100m in funding in total.
Jun 16, 2021Camp4 collects $45m capital injection
Kraft Group has once again participated in a funding round for the RNA drug developer, having backed its series A round three years ago.
Jun 16, 2021Sanity Group snatches series A funds
German Media Pool was among the participants in a $44.2m round that will fund the building of the cannabinoid product developer's production and research facility.
Jun 16, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


